Authors
Jianguo Wen, Wenjing Tao, Xiaobo Zhou
Published in
Journal of controlled release : official journal of the Controlled Release Society. Pages 115370. Sep 18, 2026. Epub Sep 18, 2026.
Abstract
Messenger RNA (mRNA) therapeutics have revolutionized vaccine development and are rapidly expanding into cancer immunotherapy, infectious diseases, regenerative medicine, and protein replacement therapies. While considerable efforts have focused on maximizing antigen expression and short term immune responses, durable therapeutic efficacy ultimately depends on the establishment of long lasting immune memory. Emerging evidence suggests that immune memory is not merely a passive consequence of antigen expression but can be actively shaped through the rational engineering of antigen persistence, delivery, and immune programming. In this review, we propose immune memory engineering as a unifying framework for mRNA therapeutics that achieve durable immune protection. We examine three interconnected biological determinants of immune memory, including antigen persistence, antigen trafficking, and innate and spatial programming, and discuss how LNP engineering, formulation parameters, and tissue specific delivery quantitatively influence memory formation. We further highlight how artificial intelligence and multiomics approaches can integrate these determinants into predictive design strategies for optimizing durable immune responses. Together, these advances position immune memory engineering as an emerging design paradigm for developing next generation mRNA therapeutics with durable, controllable, and increasingly personalized immune protection.
PMID:
42759666
Bibliographic data and abstract were imported from PubMed on 19 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 12
- Comments 0